US Clinical Development& Medical Affairs-General Medicine AIN457/Secukinumab Clinical Trial Protocol CAIN457FUS01 / NCT02798211 A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the safety and efficacy of secukinumab 300 mg and 150 mg in adult patients with More @Wikipedia
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.